This was introduced by Kay in 1953 (Kay, 1953 and is accepted as a reliable means of measuring acid secretion. There is general agreement that the dose of histamine acid phosphate used (0.04 mg/kg body weight) evokes a maximal or near maximal acid response. In recent years other stimulants of the parietal cell mass have been introduced and these, in the doses indicated in Table 1 also evoke near maximal acid outputs.
For routine clinical purposes a single subcutaneous injection is preferred to an infusion. The combination of histamine plus an antihistaminic such as 50-100 mg mepyramine maleate is one fifth of the cost (about 10 new pence) of either histalog or pentagastrin, but because of the frequency of side-effects Paper read at the National MllClinK, London. January. 1970 histamine is seldom used these days. In the doses indicated there is little difference between the acid output following histalog and pentagastrin, the cost is about the same and neither requires an antihistaminic. Because side-effects may be marginally fewer with pentagastrin this may well become the parietal cell stimulant of choice, 6 p.g/kg body weight ofpentagastrin may be given as a single subcutaneous injection.
The acid output may be expressed in various ways and the most widely used is mmol HCI/h. This figure can be calculated in different ways depending upon how the collection has been made: by pooling four 15 min. samples, by doubling the peak 30 min. output or thrice the acid output collected between the 10-30 min. post-injection period (Isenberg et al., 1968; Multicentre Study, 1969) .
Together with the stimulated acid output it is necessary to collect a basal (unstimulated) sample. This is obtained as a 1h collection prior to the stimulus. There is little to support the concept that an overnight (12h) collection provides more information and the basal hourcollectioniscertainlymorepleasant for the patient. It is important that control values be established for each centre undertaking the test. 
Value of acid studies
The question must now be answered as to the clinical value of gastric acid studies and Kay (1967) has questioned their value as a clinical tool. Acid studies cannot be used in the diagnosis of peptic ulcer disease-the definitive diagnosis is established by barium studies. Table 2 shows that the overlap in acid output between controls and patients with duodenal ulcer, gastric ulcer and gastric cancer is too great for individual discrimination. The test is generally of no value in the distinction between benign and malignant gastric ulcer unless achlorhydria is demonstrated-this is evidence in favour of malignancy. The overlap prevents the test being of value in the diagnosis of 'X-ray negative dyspepsia'. Acid studies help neither in deciding the type of surgery for peptic ulcers nor in predicting the likelihood of a recurrence of the ulcer.
The test is of help in the diagnosis of the ZollingerEllison syndrome but the best diagnostic information is given by the basal acid output: a gastrin-producing tumour should be considered when the output is 15 mmoljh or more and values greater than 10 mmoljh are very suspicious (Aoyagi and Summerskill 1966) . Equally the demonstration of an histaminefast achlorhydria is of value in the diagnosis of Addisonian pernicious anaemia. However, in time, the routine measurement of serum gastrin levels and gastric juice intrinsic factor content may well replace acid studies in these diseases (Grossman et al., 1963; Bouchier, 1969) .
Tests of vagotomy
The assessment of vagal function following vagotomy remains an unsolved problem. Firstly there is the insurmountable difficulty of making an adequate collection from the post-operative stomach and then there is confusion in how to interpret the results. The test (the Hollander Test) consists of an intravenous injection of 10-20 units of soluble insulin (or 0.1 unit/kg body weight) following a basal 2 h collection: it is necessary to demonstrate a fall in blood sugar to at least 35 mg/loo ml as evidence of adequate vagal stimulation. A positive test which indicates incomplete vagotomy is suggested by a consideration of the following criteria:
1. an acid output exceeding 1 mmol in any postinsulin hour; 2. an acid output in the 2 h after insulin which is increased by 0.5 mmol or more over the basal 1 period; 3. a rise in acid greater than 2 mmol;
a rise in volume;
5. a basal secretion greater than 2 mmoJjh.
There is no general agreement as to what constitutes a positive response. The separation of acid output into an early (within 45 min. following injection) and a late positive response probably has no clinical meaning (Bums et al., 1969) . Furthermore, Isenberg et al., (1969) have shown that before a standard dose of insulin can be used, further tests must be undertaken to determine whether the dose required for peak response is the same in the partially vagotomised as in the intact subject. This test is at present in an unsatisfactory state and provides little useful information. On the same theme, there is little to be gained from performing a 'medical vagotomy' or an agumented histamine test after gastric surgery (Johnston et al., 1966; Gillespie et al., 1%8) .
Pancreatic function tests
Compared to the stomach the present position of pancreatic function tests is chaotic and confused. Unfortunately there is no pancreatic function test comparable to the augmented histamine test. The best guide to the state of the gland is given by a combination of studies including the serum amylase, a glucose tolerance test, a faecal fat estimation, a test of pancreatic exocrine secretion and an appropriate radiological examination (Bouchier, 1969; 1970) .
Both secretin and pancreozymin are used as stimulants either singly or in combination. There are variations in the route of administration, the dose and the way of recording pancreatic electrolyte and enzyme output. Furthermore, the hormones are not universally available and are liable to vary in potency from one batch to another. The Boots preparation is not comparable, dose-for-dose, with the Swedish material.
There is a paucity of published work establishing the range of results for anyone particular method. In the face of so much uncertainty it is difficult to single out any method as being the best test of exocrine function but one of the most reliable tests is the response of volume and bicarbonate following an intravenous dose of 1 unit secretin/kg body weight. Duodenal collection of fluid and bicarbonate is made for 80 min. The normal values for volume and bicarbonate concentration are shown in Table 3 . (ml) mmol/l Henke et al., 1961 >60 >60 Zieve et al., 1966 >80 >70 Hartley et al., 1966 >100 >60
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Bicarbonate is usually expressed as a concentration although it has been claimed that output may be more accurate. In general there is a reduction in volume and bicarbonate in pancreatitis and in volume only in cancer. The test has been varied by using 2 units of secretin/kg body weight (Hartley et al.,1966) or combining secretin and pancreozyrnin (Wormsley, 1969) . However, regardless of the variations it appears that while reasonably good discrimination can be achieved between normal and diseased glands inflammation and cancer cannot be separated with confidence. The most reliable enzyme to measure is trypsin but it is uncertain whether this measurement adds to the diagnostic accuracy of that test.
It is stressed that careful attention and personal supervision is necessary during the duodenal intubation and aspiration for best results to be obtained. As with the stomach it is necessary for the range of normal to be established on the population being seen by the laboratory.
Because of the difficulties with secretin-pancreozymin tests a test meal has been introduced as a stimulus for enzyme output (Lundh, 1962) . This test, known as the Lundh test, involves duodenal intubation, the feeding of a test meal and the assay of enzymes in the aspirate. Wiggins (1967) has described a simple method for estimating tryptic activity using Nbenzoyl-arginine-ethyl-ester as the substrate. The range of values found in the test is shown in Table 4 . On the whole there is good discrimination between normal and diseased glands (Cook et al., 1967; McCarthy and Brown, 1969 (Marks and Bank, 1963) . Another such test is the estimation of faecal chymotrypsin and this can be performed on out-patients by an analysis of two stool samples per patient (Amman et al., 1968) . On the whole these screening procedures have not been widely adopted.
In the absence of a single reliable clinical test of pancreatic function an assessment of the state of the gland must be attempted from a combination of chemical and radiological studies. It is interesting to compare the efficacy of gastric and pancreatic investigations: functional, radiological and histological studies enable a complete diagnosis to be made of gastric pathology-this is often not the case with the pancreas.
